Europa & Palestine News « Europa & Middle East News
2013 UN World Drug Report: Alarming Rise in New Drugs
During a press conference held today at the United Nations headquarters in Vienna, the attending journalists expressed concern about the lack of effectiveness and feasibility of the actions taken by UNODC to reduce the global marketing of drugs, demanding from the Office on Drugs and Crime to why the measures taken by the UNODC are not reducing the marketing of drugs. Journalists also asked how the UNODC deals with cases when UN member States are themselves involved in drug trafficking or do not control and monitor the drug market, or are legalizing drugs in their jurisdiction.
While new harmful substances have been emerging with unfailing regularity on the drug scene, the international drug control system is floundering, for the first time, under the speed and creativity of the phenomenon known as new psychoactive substances (NPS).
(a) The substance remains on the market, but its use declines immediately. Examples include mephedrone in the United Kingdom of Great Britain and Northern Ireland, BZP in New Zealand, “legal highs” in Poland, mephedrone in Australia and MDPV in the United States of America;(b Use of the substance declines after a longer interval, maybe a year or more (e.g. ketamine in the United States);(c) Scheduling has little or no immediate impact on the use of the substance, e.g. 3,4-methylenedioxy- Nmethylamphetamine (MDMA), commonly known as “ecstasy”, in the United States and other countries.
To read the UNODC Executive Director’s statement on International Day against Drug Abuse and Illicit Trafficking, Click here.